当前位置:首页 - 行情中心 - 人福医药(600079) - 财务分析 - 利润表

人福医药

(600079)

  

流通市值:297.27亿  总市值:315.86亿
流通股本:15.36亿   总股本:16.32亿

利润表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
一、营业总收入24,524,740,572.6918,111,717,932.0412,382,998,383.936,225,735,090.21
营业收入24,524,740,572.6918,111,717,932.0412,382,998,383.936,225,735,090.21
二、营业总成本21,417,059,137.0815,716,222,804.2610,673,265,170.645,431,915,788.85
营业成本13,290,991,557.359,806,286,791.956,736,431,518.173,335,010,236.1
税金及附加191,747,055.27124,599,985.0697,193,328.6549,550,717.62
销售费用4,397,798,774.973,360,835,097.392,361,665,417.951,272,496,388.82
管理费用1,770,060,888.321,211,650,068.82724,130,879.81367,722,651.9
研发费用1,461,942,028.61,001,169,520.67641,222,312285,358,236.04
财务费用304,518,832.57211,681,340.37112,621,714.06121,777,558.37
其中:利息费用354,141,696.04267,659,212.16173,458,585.7894,235,280.81
其中:利息收入58,771,065.0239,494,643.8818,573,116.397,210,554.99
加:公允价值变动收益136,854,734.94104,016,622.4988,927,090.7690,650,758.98
加:投资收益206,785,478.83196,144,860.74188,012,813.8106,784,674.41
资产处置收益-1,084,924.95655,096.1237,940.24391,415.86
资产减值损失(新)-61,407,302.82-28,746,644.43-29,215,446.98249,327.65
信用减值损失(新)-147,357,909.38-54,213,689.24-47,870,921.41-24,472,100.75
其他收益205,702,658.11129,881,762.1996,621,572.7643,961,299.67
营业利润平衡项目0000
四、营业利润3,447,174,170.342,743,233,135.652,006,246,262.461,011,384,677.18
加:营业外收入8,284,582.891,410,000.851,948,752.762,250,674.52
减:营业外支出71,629,921.2637,366,699.4715,746,079.7210,428,505.59
利润总额平衡项目0000
五、利润总额3,383,828,831.972,707,276,437.031,992,448,935.51,003,206,846.11
减:所得税费用568,563,020.27424,125,720.65301,761,452.13142,093,319.6
六、净利润2,815,265,811.72,283,150,716.381,690,687,483.37861,113,526.51
持续经营净利润2,815,265,811.72,283,150,716.381,690,687,483.37861,113,526.51
归属于母公司股东的净利润2,134,484,688.961,768,711,274.431,323,812,531.77665,316,964.81
少数股东损益680,781,122.74514,439,441.95366,874,951.6195,796,561.7
(一)基本每股收益1.321.090.820.41
(二)稀释每股收益1.311.090.810.41
八、其他综合收益32,370,529.4788,219,201.6662,058,474.861,583,453.59
归属于母公司股东的其他综合收益36,319,681.8287,940,098.1758,409,343.131,349,275.18
九、综合收益总额2,847,636,341.172,371,369,918.041,752,745,958.23862,696,980.1
归属于母公司股东的综合收益总额2,170,804,370.781,856,651,372.61,382,221,874.9666,666,239.99
归属于少数股东的综合收益总额676,831,970.39514,718,545.44370,524,083.33196,030,740.11
公告日期2024-03-292023-10-272023-08-252023-04-28
审计意见(境内)标准无保留意见
TOP↑